Holen Sie sich die Stockscreener-App
59.92
0.62%
0.37
Schlusskurs vom Vortag:
$59.55
Offen:
$60.085
24-Stunden-Volumen:
860.10K
Relative Volume:
0.57
Marktkapitalisierung:
$8.01B
Einnahmen:
$2.51B
Nettoeinkommen (Verlust:
$185.56M
KGV:
44.72
EPS:
1.34
Netto-Cashflow:
$517.59M
1W Leistung:
+1.25%
1M Leistung:
-14.92%
6M Leistung:
-28.08%
1J Leistung:
-9.46%
1-Tages-Spanne:
$59.55
$60.35
1-Wochen-Bereich:
$57.88
$60.35
52-Wochen-Spanne:
$54.48
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
59.92 | 8.01B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.GMED - Longview News-Journal
Collegeville Office Buildings Sell to Globus Medical with Staggering Price Cut - VISTA.Today
Globus Medical Approves Key Proposals at Annual Meeting - TipRanks
Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential - Yahoo Finance
Adult Spinal Deformity Market Detailed in New Research Report - openPR.com
Globus Medical Inc (GMED) Stock Price, Trades & News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED - FinancialContent
Collegeville office buildings sell for 81% less than previous sale price - The Business Journals
Globus Medical announces share buyback program of up to $500M - MSN
Globus Medical’s $250M Nevro Bet: Can This Bold Acquisition Disrupt Neuromodulation? - Smartkarma
BTIG Downgrades Globus Medical (BMV:GMED) - Nasdaq
Globus Medical Announces $500M Share Repurchase Program to Boost Shareholder Value - MSN
BTIG cuts Globus Medical stock rating to neutral, removes PT By Investing.com - Investing.com Canada
BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns - Insider Monkey
Globus Medical (GMED): JMP Securities Reiterates Market Perform Rating | GMED Stock News - GuruFocus
Analysts downgrade Globus Medical on fears of ‘foundational cracks’ - MassDevice
Globus Medical (GMED) Downgraded by BTIG to Neutral | GMED Stock News - GuruFocus
This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday - Benzinga
Assessing Globus Medical: Insights From 4 Financial Analysts - Benzinga
BTIG Downgrades Globus Medical to Neutral From Buy - marketscreener.com
Future STEM Leaders: Chester County Futures Students Explore Careers at Globus Medical - VISTA.Today
Globus Medical (GMED) Downgraded by BTIG Over Spine Business Con - GuruFocus
JMP maintains Market Perform on Globus Medical stock By Investing.com - Investing.com India
JMP maintains Market Perform on Globus Medical stock - Investing.com
Globus Medical, Inc. (NYSE:GMED) Stock Holdings Lifted by Cetera Investment Advisers - Defense World
Globus Medical’s SWOT analysis: spine leader faces headwinds, eyes robotics growth - Investing.com Canada
ATTENTION Globus Medical, Inc. (GMED) Investors: Possible FraudContact Levi & Korsinsky Today - Louisiana First News
Globus Medical’s Q1:2025 Op Profit Soars - Orthopedics This Week
Deutsche Bank AG Acquires 1,157 Shares of Globus Medical, Inc. (NYSE:GMED) - Defense World
Spinal Implants and Surgery Devices Market Is Booming So Rapidly with Zimmer Biomet, Globus Medical - openPR.com
Globus Medical And 2 Other Growth Companies Insiders Are Betting On - Yahoo Finance
Ameriprise Financial Inc. Grows Position in Globus Medical, Inc. (NYSE:GMED) - Defense World
Globus Inks Deal for Robotic Surgical Company - Medical Product Outsourcing
Globus Medical Faces Shareholder Lawsuit - Medical Product Outsourcing
Globus Medical Inc (GMED) Stock Price Up 5.5% on May 16 - GuruFocus
Globus Medical, Inc. (NYSE:GMED) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Globus Medical (GMED) Approves $500M Share Buyback Program - GuruFocus
Globus Medical (GMED) Initiates $500M Share Buyback Program | GM - GuruFocus
Globus Medical announces $500M share repurchase program - MassDevice
We Think Globus Medical's (NYSE:GMED) Profit Is Only A Baseline For What They Can Achieve - Yahoo Finance
Levi & Korsinsky Reminds Shareholders of an Investigation into Globus Medical, Inc. (GMED) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Globus Medical Announces $500 Million Share Repurchase Program | GMED Stock News - GuruFocus
Globus Medical launches $500 million stock buyback By Investing.com - Investing.com Canada
Globus Medical Announces $500 Million Share Repurchase Program - citybiz
Globus Medical Announces $500M Share Buyback Program - TipRanks
Globus Medical launches $500 million stock buyback - Investing.com Australia
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):